In the relapse and refractory phases of active MM, inflammatory factors such as vascular endothelial growth factor (VEGF), fibroblast growth factor 2 (FGF-2), and hepatocyte growth factor (HGF) are activated and recruited, leading to macrophage activation. This evidence concerns the gene HGF and Miyoshi myopathy.